Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 16/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11969436 | 1.00 | MAOA (0.54) | MAOAMAOBCYP3A4CYP2D6KCNH2 | |
| SCHEMBL13428685 | 0.88 | MAOA (0.68) | MAOAMAOBCYP3A4CYP2D6KCNH2 | |
| SCHEMBL11969343 | 0.88 | MAOA (0.68) | MAOAMAOBCYP3A4CYP2D6KCNH2 | |
| SCHEMBL11969868 | 0.86 | MAOA (0.56) | MAOAMAOBCYP3A4CYP2D6KCNH2 | |
| SCHEMBL11969478 | 0.82 | CALML3 (0.47) | MAOAMAOBCYP3A4CYP2C9 | |
| SCHEMBL11969072 | 0.82 | MAOA (0.58) | MAOAMAOBCYP3A4CYP2D6KCNH2 | |
| SCHEMBL5838470 | 0.79 | MAOA (0.59) | MAOAMAOBCYP3A4CYP2D6KCNH2 | |
| SCHEMBL3325038 | 0.79 | MAOA (0.60) | MAOAMAOBCYP3A4CYP2D6KCNH2 | |
| SCHEMBL11969084 | 0.77 | MAOA (0.60) | MAOAMAOB | |
| SCHEMBL5235825 | 0.76 | MAOA (0.57) | MAOAMAOBCYP3A4CYP2D6KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010036000-A2 | NOVEL OXAZOLIDINONE DERIVATIVES WITH CYCLIC AMIDOXIME OR CYCLIC AMIDRAZONE AND PHARMACEUTICAL COMPOSITIONS THEREOF | LEGOCHEM BIOSCIENCE LTD. (KR) | 2010-04-01 | — | — | WO | disclosed |